Showing 171-180 of 3101 results for "".
Narcolepsy, Idiopathic Hypersomnia, and General Sleep Disorders
https://practicalneurology.com/programs/practical-neurology/narcolepsy-idiopathic-hypersomnia-and-general-sleep-disorders/30083/In this episode, Rajkumar Dasgupta, MD, Clinical Associate Professor at Keck School of Medicine of USC and sleep specialist, provides an in-depth review of what's new in sleep disorders, with a special focus on updates in narcolepsy and idiopathic hypersomnia.INTREPID (A randomized, double-blind, sham-controlled study of subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of individuals with Parkinson disease; NCT01839396)
https://practicalneurology.com/diseases-diagnoses/movement-disorders/intrepid-subthalamic-nucleus-deep-brain-stimulation-parkinson-disease/48741/Jerrold L. Vitek, MD, PhD, Head of the Neurology Department at the University of Minnesota, Minneapolis, MN, provides an overview of the INTREPID clinical trial which assessed subthalamic nucleus deep brain stimulation in patients with Parkinson disease.Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-dementia-and-psychosis-in-individuals-with-parkinson-disease/39935/Jorge Patino, MD, Movement Disorders Fellow, University of Cincinnati, Cincinnati, OH, provides an overview of dementia and psychosis in people with Parkinson disease, including clinical approaches for the diagnosis of these conditions, and nonpharmacologic, environmental, and pharmacologic treatmenHow to Communicate the Results of Alzheimer Disease Biomarker Tests with Patients
https://practicalneurology.com/videos/neurology-in-motion/how-to-communicate-the-results-of-alzheimer-disease-biomarker-tests-with-patients/39733/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses how to communicate the results of Alzheimer disease biomarker tests with patients.Factors Influencing the Selection of Blood Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-blood-tests-for-alzheimer-disease/39224/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of blood tests for Alzheimer disease.Diplopia and Brisk Reflexes in a 40-Year-Old Man
https://practicalneurology.com/columns/practice-management/diplopia-and-brisk-reflexes-in-a-40-year-old-man/30675/About the Cover Artist
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/audrius-v-plioplys-md-is-a-neurologist-who-has-merged-the-research-lab-with-the-art-studio/31667/Audrius V. Plioplys, MD, is a neurologist who has merged the research lab with the art studio.Early Diagnosis, Effective Patient Partnerships, and Other Keys to Optimizing Multiple Sclerosis Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/early-diagnosis-effective-patient-partnerships-and-other-keys-to-optimizing-multiple-sclerosis-therapy/30485/Standardizing imaging protocols and employing strategies to boost adherence can lead to better treatment outcomes.Neuro-Ophthalmology Notions: The Optic Nerve as Topographic Marker in the 2024 McDonald Diagnostic Criteria for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neuro-ophthalmology-notions-the-optic-nerve-as-topographic-marker-in-the-2024-mcdonald-diagnostic-criteria-for-multiple-sclerosis/35447/Neuro-ophthalmic evaluations assist in early diagnosis of multiple sclerosis.Sleep Disorders in Patients With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/sleep-disorders-in-patients-with-multiple-sclerosis/30213/Identifying and treating sleep problems can help optimize the well-being and function of patients with multiple sclerosis.